Onconova Therapeutics
ONTX
$1.00
Share price
-0.47%
Change (1 day)
-15.65%
Change (1 year)
Categories
Onconova Therapeutics (ONTX) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $12.52 M
According to Onconova Therapeutics's latest financial reports the company's total liabilities are $12.52 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Onconova Therapeutics - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $11.06 M | 18.22% |
| 2021-12-31 | $9.35 M | -32.24% |
| 2020-12-31 | $13.81 M | 14.14% |
| 2019-12-31 | $12.1 M | -3.48% |
| 2018-12-31 | $12.53 M | -20.86% |
| 2017-12-31 | $15.84 M | -12.52% |
| 2016-12-31 | $18.1 M | 43.64% |
| 2015-12-31 | $12.6 M | -46.85% |
| 2014-12-31 | $23.71 M | -2.22% |
| 2013-12-31 | $24.25 M | -89.98% |
| 2012-12-31 | $0.24 B | 69.48% |
| 2011-12-31 | $0.14 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $19.80 B | 158,098.23% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $80.87 M | 545.87% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $0.13 B | 999.11% | 🇺🇸 USA |
 Array Technologies ARRY | $1.09 B | 8,655.13% | 🇺🇸 USA |